ACCORD HEALTHCARE, INC.: Drug Recall
Recall #D-0006-2026 · 09/16/2025
Class II: Risk
Recall Details
- Recall Number
- D-0006-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ACCORD HEALTHCARE, INC.
- Status
- Ongoing
- Date Initiated
- 09/16/2025
- Location
- Raleigh, NC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 54,432 bottles
Reason for Recall
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Product Description
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.
Distribution Pattern
Nationwide in the US
Other Recalls by ACCORD HEALTHCARE, INC.
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.